Koninklijke Philips Total Assets 2010-2025 | PHG
- Koninklijke Philips total assets for the quarter ending March 31, 2025 were $28.620B, a 17.22% decline year-over-year.
- Koninklijke Philips total assets for 2024 were $31.355B, a 1.48% decline from 2023.
- Koninklijke Philips total assets for 2023 were $31.826B, a 1.57% decline from 2022.
- Koninklijke Philips total assets for 2022 were $32.333B, a 11.73% decline from 2021.
Koninklijke Philips Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $31,355 |
2023 | $31,826 |
2022 | $32,333 |
2021 | $36,630 |
2020 | $31,657 |
2019 | $30,258 |
2018 | $30,728 |
2017 | $28,614 |
2016 | $35,747 |
2015 | $34,396 |
2014 | $37,688 |
2013 | $35,278 |
2012 | $37,399 |
2011 | $40,344 |
2010 | $42,853 |
2009 | $42,573 |
Koninklijke Philips Quarterly Total Assets (Millions of US $) |
|
---|---|
2025-03-31 | $28,620 |
2024-06-30 | $31,741 |
2023-06-30 | $32,173 |
2023-03-31 | $0 |
2022-06-30 | $34,576 |
2021-06-30 | $34,949 |
2020-06-30 | $30,262 |
2019-06-30 | $29,620 |
2018-06-30 | $29,605 |
2017-06-30 | $32,378 |
2016-12-31 | $35,747 |
2016-09-30 | $34,480 |
2016-06-30 | $35,120 |
2016-03-31 | $32,828 |
2015-12-31 | $34,396 |
2015-09-30 | $33,588 |
2015-06-30 | $34,167 |
2015-03-31 | $35,885 |
2014-12-31 | $37,688 |
2014-09-30 | $37,047 |
2014-06-30 | $35,199 |
2014-03-31 | $35,597 |
2013-12-31 | $35,278 |
2013-09-30 | $36,197 |
2013-06-30 | $36,075 |
2013-03-31 | $37,944 |
2012-12-31 | $37,399 |
2012-09-30 | $36,387 |
2012-06-30 | $37,536 |
2012-03-31 | $38,851 |
2011-12-31 | $40,344 |
2011-09-30 | $39,236 |
2011-06-30 | $39,052 |
2011-03-31 | $40,982 |
2010-12-31 | $42,853 |
2010-09-30 | $41,868 |
2010-06-30 | $43,788 |
2010-03-31 | $44,166 |
2009-12-31 | $42,573 |
2009-09-30 | $41,983 |
2009-06-30 | $39,559 |
2009-03-31 | $41,534 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $21.553B | $19.503B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
Boston Scientific (BSX) | United States | $154.617B | 38.71 |
Stryker (SYK) | United States | $145.191B | 30.36 |
EssilorLuxottica (ESLOY) | France | $128.660B | 0.00 |
Medtronic (MDT) | Ireland | $104.194B | 14.77 |
Haleon (HLN) | United Kingdom | $50.678B | 28.85 |
Lonza Group Ag (LZAGY) | Switzerland | $49.121B | 0.00 |
ResMed (RMD) | United States | $35.889B | 26.96 |
GE HealthCare Technologies (GEHC) | United States | $32.579B | 15.47 |
Agilent Technologies (A) | United States | $31.612B | 20.53 |
Terumo (TRUMY) | Japan | $27.743B | 36.03 |
Insulet (PODD) | United States | $22.770B | 89.38 |
Zimmer Biomet Holdings (ZBH) | United States | $18.259B | 11.73 |
Baxter (BAX) | United States | $15.693B | 11.72 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.530B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
Demant (WILYY) | Denmark | $8.637B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.236B | 21.70 |
Lantheus Holdings (LNTH) | United States | $5.132B | 12.95 |
Prestige Consumer Healthcare (PBH) | United States | $4.168B | 18.62 |
Perrigo (PRGO) | Ireland | $3.726B | 9.44 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.248B | 14.79 |
ICU Medical (ICUI) | United States | $3.162B | 23.32 |
Envista Holdings (NVST) | United States | $3.141B | 26.10 |
GN Store Nord (GNNDY) | Denmark | $2.200B | 18.22 |
QuidelOrtho (QDEL) | United States | $2.144B | 14.74 |
LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
AtriCure (ATRC) | United States | $1.660B | 0.00 |
Acuren (TIC) | United States | $1.336B | 0.00 |
Neogen (NEOG) | United States | $1.326B | 16.97 |
AdaptHealth (AHCO) | United States | $1.225B | 12.44 |
Kestra Medical Technologies (KMTS) | United States | $1.174B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.103B | 24.81 |
BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.993B | 12.69 |
InMode (INMD) | Israel | $0.910B | 9.17 |
CeriBell (CBLL) | United States | $0.621B | 0.00 |
Evolus (EOLS) | United States | $0.600B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.593B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
Valneva SE (VALN) | France | $0.533B | 0.00 |
Owens & Minor (OMI) | United States | $0.504B | 4.18 |
Capricor Therapeutics (CAPR) | United States | $0.486B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
Surmodics (SRDX) | United States | $0.418B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
SNDL (SNDL) | Canada | $0.342B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.324B | 11.91 |
Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
ZimVie (ZIMV) | United States | $0.245B | 11.14 |
Cerus (CERS) | United States | $0.242B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.240B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
Quanterix (QTRX) | United States | $0.205B | 0.00 |
Brainsway (BWAY) | Israel | $0.202B | 53.50 |
Biote (BTMD) | United States | $0.193B | 5.43 |
Omeros (OMER) | United States | $0.184B | 0.00 |
Organigram Global (OGI) | Canada | $0.181B | 0.00 |
High Tide (HITI) | Canada | $0.181B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.176B | 14.30 |
Exagen (XGN) | United States | $0.143B | 0.00 |
FitLife Brands (FTLF) | United States | $0.135B | 16.62 |
Jin Medical (ZJYL) | China | $0.119B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
Agape ATP (ATPC) | $0.093B | 0.00 | |
Fonar (FONR) | United States | $0.089B | 11.48 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
MacroGenics (MGNX) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.077B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
Zynex (ZYXI) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.070B | 0.00 |
Apyx Medical (APYX) | United States | $0.063B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
ImmuCell (ICCC) | United States | $0.056B | 0.00 |
Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
United Health Products (UEEC) | United States | $0.052B | 0.00 |
Modular Medical (MODD) | United States | $0.047B | 0.00 |
United-Guardian (UG) | United States | $0.039B | 13.45 |
Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.031B | 41.74 |
Safety Shot (SHOT) | United States | $0.026B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |